2015
DOI: 10.1016/j.cjca.2015.07.525
|View full text |Cite
|
Sign up to set email alerts
|

Real World Usage of Oral Anticoagulants in Patients Undergoing Electrical Cardioversion for Atrial Tachyarrhythmias

Abstract: BACKGROUND: Dysautonomia is thought to affect up to 1% of teenagers and is associated with significant impairments in quality of life (QoL). There are limited therapeutic options for physicians managing adolescents with dysautonomia. Typically, advice is given about fluid and salt balance, as well as physical counter pressure movements. In this pilot study, we sought to determine whether adolescents with dysautonomia improve their QoL following a prescribed body weight resistance training program. METHODS: Par… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Although it is true that patients enrolled in RCTs are likely different in regard to medication compliance and baseline characteristics, real-life data examining the safety of withholding TEE in patients appropriately anticoagulated on DOAC confirm RCT data. 24,25 Kaplan et al 25 reviewed more than 600 patients who underwent cardioversion after 3 weeks of DOAC therapy and observed a low stroke rate at 30 days (2/600). It is important to note, however, that the safety of using DOAC in cardioversion is based on the low incidence of thromboembolic events rather than LAAT.…”
Section: Discussionmentioning
confidence: 99%
“…Although it is true that patients enrolled in RCTs are likely different in regard to medication compliance and baseline characteristics, real-life data examining the safety of withholding TEE in patients appropriately anticoagulated on DOAC confirm RCT data. 24,25 Kaplan et al 25 reviewed more than 600 patients who underwent cardioversion after 3 weeks of DOAC therapy and observed a low stroke rate at 30 days (2/600). It is important to note, however, that the safety of using DOAC in cardioversion is based on the low incidence of thromboembolic events rather than LAAT.…”
Section: Discussionmentioning
confidence: 99%